A0745 - Fluorine-18 (18F) Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography (PET) and the diagnosis and staging of primary Prostate Cancer (PCa)

Autor: Byrne, M.H.V., Ranasinha, N., Mercader, C., Raslan, M., Lewis, F., Gorgoraptis, S., Sathanapally, G., Lopes Vieira, A.C., Golebka, J., Peiris, B., Tuthill, M., Protheroe, A., Camilleri, P., Turner, P., Andrade, G., Miah, S., Leslie, T., Bryant, R., Hamdy, F., Macpherson, R., Gleeson, F., Lopez, F., Lamb, A.D.

Publikováno v: In European Urology February 2022 81 Supplement 1:S1105-S1106

Mutagenesis on a complex mouse genetic background by site-specific nucleases.

Autor: Davies B; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK.; Francis Crick Institute, 1 Midland Road, London, UK., Trelfa L; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Rashbrook VS; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Drydale E; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Martin R; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Bai B; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Golebka J; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Biggs DS; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Channon KM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK., Bhattacharya S; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK., Douglas G; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, BHF Centre of Research Excellence, John Radcliffe Hospital, University of Oxford, Oxford, UK. gillian.douglas@cardiov.ox.ac.uk.; Wellcome Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, UK. gillian.douglas@cardiov.ox.ac.uk.

Publikováno v: Transgenic research [Transgenic Res] 2024 Oct; Vol. 33 (5), pp. 415-426. Date of Electronic Publication: 2024 Aug 01.